Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 93 (RNA5SP93) is classified as a pseudogene of the 5S ribosomal RNA gene[2]. The canonical 5S ribosomal RNA (rRNA) is a crucial structural and functional component of the large subunit of the ribosome, involved in the stabilization of ribosome structure, facilitating translation, and associated with protein synthesis in eukaryotes and prokaryotes[1][3][4][5]. However, pseudogenes such as RNA5SP93 are non-functional copies of genes that typically do not encode functional RNA or protein products. Most pseudogenes, including this one, do not have known biological functions, are not involved in recognized disease processes, and are not targeted by approved or experimental drugs[2][6]. There is no evidence that RNA5SP93 acts as a therapeutic target or biomarker, nor is it recognized as a receptor, enzyme, transporter, or similar druggable protein class. Many pseudogenes may still be of interest for studies in genomics or transcriptomics but are generally not considered practical targets in pharmacology or clinical research[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 93 (RNA5SP93).